126 related articles for article (PubMed ID: 2986192)
1. Characterization of platelet alpha 2 adrenoceptors and measurement in control and depressed subjects.
Campbell IC; McKernan RM; Checkley SA; Glass IB; Thompson C; Shur E
Psychiatry Res; 1985 Jan; 14(1):17-31. PubMed ID: 2986192
[TBL] [Abstract][Full Text] [Related]
2. Alpha 2-adrenergic receptors in platelet membranes of depressed patients: increased affinity for 3H-yohimbine.
Wolfe N; Cohen BM; Gelenberg AJ
Psychiatry Res; 1987 Feb; 20(2):107-16. PubMed ID: 3033726
[TBL] [Abstract][Full Text] [Related]
3. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
4. Alpha 2-adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs.
García-Sevilla JA; Hollingsworth PJ; Smnith CB
Eur J Pharmacol; 1981 Sep; 74(4):329-41. PubMed ID: 6271559
[TBL] [Abstract][Full Text] [Related]
5. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
Schloos J; Wellstein A; Palm D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026
[TBL] [Abstract][Full Text] [Related]
6. Binding of [3H]-p-aminoclonidine to alpha 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes.
Piletz JE; Andorn AC; Unnerstall JR; Halaris A
Biochem Pharmacol; 1991 Jul; 42(3):569-84. PubMed ID: 1677571
[TBL] [Abstract][Full Text] [Related]
7. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.
Piletz JE; Halaris A; Nelson J; Qu Y; Bari M
J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655
[TBL] [Abstract][Full Text] [Related]
8. Labelling of human platelet alpha 2-adrenoceptors with the full agonist [3H](-)adrenaline.
Garcia-Sevilla JA; Fuster MJ
Eur J Pharmacol; 1986 May; 124(1-2):31-41. PubMed ID: 3013661
[TBL] [Abstract][Full Text] [Related]
9. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
10. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
[TBL] [Abstract][Full Text] [Related]
11. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
12. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
Zonnenchein R; Diamant S; Atlas D
Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
[TBL] [Abstract][Full Text] [Related]
13. Lesioning of serotoninergic and noradrenergic nerve fibres of the rat brain does not decrease binding of 3H-clonidine and 3H-rauwolscine to cortical membranes.
Gross G; Göthert M; Glapa U; Engel G; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):229-35. PubMed ID: 2984581
[TBL] [Abstract][Full Text] [Related]
14. Acute and long-term regulation of brain alpha 2-adrenoceptors after manipulation of noradrenergic transmission in the rat.
Giralt MT; García-Sevilla JA
Eur J Pharmacol; 1989 May; 164(3):455-66. PubMed ID: 2569977
[TBL] [Abstract][Full Text] [Related]
15. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
Paris H; Galitzky J; Senard JM
Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
[TBL] [Abstract][Full Text] [Related]
16. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
Mukherjee A
Biochim Biophys Acta; 1981 Aug; 676(2):148-54. PubMed ID: 6114754
[TBL] [Abstract][Full Text] [Related]
17. Alpha 2-adrenergic receptor sensitivity in depressed patients: relation between 3H-yohimbine binding to platelet membranes and clonidine-induced hypotension.
Wolfe N; Gelenberg AJ; Lydiard RB
Biol Psychiatry; 1989 Feb; 25(4):382-92. PubMed ID: 2539204
[TBL] [Abstract][Full Text] [Related]
18. Alpha-2-adrenoreceptor density on intact platelets and adrenaline-induced platelet aggregation in endurance- and nonendurance-trained subjects.
Lehmann M; Hasler K; Bergdolt E; Keul J
Int J Sports Med; 1986 Jun; 7(3):172-6. PubMed ID: 3015811
[TBL] [Abstract][Full Text] [Related]
19. Decrease of clonidine binding affinity to alpha 2-adrenoceptor by ADP-ribosylation of 41,000-dalton proteins in rat cerebral cortical membranes by islet-activating protein.
Nomura Y; Kitamura Y; Segawa T
J Neurochem; 1985 Feb; 44(2):364-9. PubMed ID: 2981281
[TBL] [Abstract][Full Text] [Related]
20. Alpha 2-adrenergic binding and action in human adipocytes. Comparison between binding to plasma membrane preparations and to intact adipocytes.
Richelsen B; Pedersen O
Eur J Pharmacol; 1985 Dec; 119(1-2):101-12. PubMed ID: 2867917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
